MFN2, ODGH, and MMAA were eventually selected for survival analysis, but only MMAA predicted better 5-year survival outcomes in female HCC patients (Figure 2B and Supplementary Figure 3; generalized Wilcoxon analysis, P = 0.0468). The gene discussed is MFN2; the disease is hepatocellular carcinoma.